Clinical Trials Browser

Gastro-enteropancreatic neuroendocrine tumor × Temozolomide × Endocrine × Clear all

NCT04919226 2025-09-10

COMPOSE

Phase 3 Active not recruiting

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

NCT04893785 2024-06-18

CABOTEM

Phase 2 Recruiting

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor